BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8867693)

  • 1. Brain tumor: immunohistochemical studies on the stress-response proteins, p53 protein and proliferating cell nuclear antigen.
    Kato S; Morita T; Hori T; Kato M; Hirano A; Herz F; Ohama E
    Noshuyo Byori; 1995; 12(2):125-32. PubMed ID: 8867693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical expression of stress-response protein (srp) 60 in human brain tumours: relationship of srp 60 to the other five srps, proliferating cell nuclear antigen and p53 protein.
    Kato S; Kato M; Hirano A; Takikawa M; Ohama E
    Histol Histopathol; 2001 Jul; 16(3):809-20. PubMed ID: 11510971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein.
    Kato S; Esumi H; Hirano A; Kato M; Asayama K; Ohama E
    Acta Neuropathol; 2003 Apr; 105(4):333-40. PubMed ID: 12624786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors.
    Kato S; Ishihara K; Shinozawa T; Yamaguchi H; Asano Y; Saito M; Kato M; Terada T; Awaya A; Hirano A; Dickson DW; Yen SH; Ohama E
    J Neuropathol Exp Neurol; 1999 May; 58(5):430-41. PubMed ID: 10331431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
    Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
    Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
    Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
    Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to stage-specific fetal brain 68-kDa glycoprotein (FGP68) revealed increased FGP68 expression in human primary brain tumors.
    Kato S; Shinozawa T; Nagashige H; Nakamura M; Asano Y; Takikawa M; Kato M; Awaya A; Hirano A; Ohama E
    Acta Neuropathol; 2002 Jul; 104(1):57-66. PubMed ID: 12070665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the expression of stress-response protein (srp) 72, srp 27, alpha B-crystallin and ubiquitin in brain tumours. An immunohistochemical investigation.
    Kato S; Hirano A; Kato M; Herz F; Ohama E
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):436-42. PubMed ID: 8278027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
    Grunnet ML; O'Neill A; Gilbert M; Hellman R
    Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.
    Cappello F; Ribbene A; Campanella C; Czarnecka AM; Anzalone R; Bucchieri F; Palma A; Zummo G
    Eur J Histochem; 2006; 50(1):25-34. PubMed ID: 16584982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
    Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
    Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.